申请人:Abbott Laboratories
公开号:US04963563A1
公开(公告)日:1990-10-16
Compounds of the formula: ##STR1## wherein n=1 or 2; R.sub.1 is lower alkoxy, lower alkyl, halo, ester, carbamate, or substituted amino; and R.sub.2 is thienyl or furyl; or R.sub.2 is ##STR2## wherein R.sub.3 and R.sub.4 are independently selected from hydrogen, halo, hydroxy, methoxy, thioalkoxy, substituted amino and lower alkyl; and pharmaceutically acceptable salts thereof. These compounds are useful as inhibitors of alpha-2-adrenergic receptors and for the treatment of glaucoma and/or controlling intraocular pressure.
式为##STR1##的化合物,其中n=1或2;R.sub.1为较低的烷氧基、较低的烷基、卤素、酯、氨基甲酸酯或取代氨基;而R.sub.2为噻吩基或呋喃基;或者R.sub.2为##STR2##其中R.sub.3和R.sub.4分别选自氢、卤素、羟基、甲氧基、硫代烷氧基、取代氨基和较低的烷基;以及其药学上可接受的盐。这些化合物可用作α-2肾上腺素受体的抑制剂,用于治疗青光眼和/或控制眼内压。